These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16978447)

  • 21. [If the brain is "divided"].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2011 Feb; 34(2):39. PubMed ID: 21428013
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
    Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
    Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maillard reaction versus other nonenzymatic modifications in neurodegenerative processes.
    Pamplona R; Ilieva E; Ayala V; Bellmunt MJ; Cacabelos D; Dalfo E; Ferrer I; Portero-Otin M
    Ann N Y Acad Sci; 2008 Apr; 1126():315-9. PubMed ID: 18079479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.
    Lee HG; Zhu X; Castellani RJ; Nunomura A; Perry G; Smith MA
    J Pharmacol Exp Ther; 2007 Jun; 321(3):823-9. PubMed ID: 17229880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
    Lim KL
    Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How do neurons die in neurodegenerative diseases?
    Kanazawa I
    Trends Mol Med; 2001 Aug; 7(8):339-44. PubMed ID: 11516993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Jellinger KA
    Acta Neuropathol; 2009 Feb; 117(2):215-6; author reply 217-8. PubMed ID: 18985364
    [No Abstract]   [Full Text] [Related]  

  • 30. Striatal beta-amyloid deposition in Parkinson disease with dementia.
    Jellinger KA
    J Neuropathol Exp Neurol; 2008 May; 67(5):484; author reply 484-5. PubMed ID: 18451728
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of autophagy in age-related neurodegeneration.
    McCray BA; Taylor JP
    Neurosignals; 2008; 16(1):75-84. PubMed ID: 18097162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?
    Armstrong RA; Lantos PL; Cairns NJ
    Neuropathology; 2008 Aug; 28(4):351-65. PubMed ID: 18433435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics of human brain aging and age-related neurodegenerative diseases.
    Jové M; Portero-Otín M; Naudí A; Ferrer I; Pamplona R
    J Neuropathol Exp Neurol; 2014 Jul; 73(7):640-57. PubMed ID: 24918636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia.
    Jellinger KA
    Neurodegener Dis; 2008; 5(3-4):118-21. PubMed ID: 18322367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling.
    Gorman AM
    J Cell Mol Med; 2008 Dec; 12(6A):2263-80. PubMed ID: 18624755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease.
    Zhu Y; Hoell P; Ahlemeyer B; Sure U; Bertalanffy H; Krieglstein J
    Neurochem Int; 2007 Feb; 50(3):507-16. PubMed ID: 17169462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current studies on neuronal death and neurodegenerative diseases].
    Imaizumi K; Hara H; Ito Y; Takuma K; Nunomura A
    Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):477-82. PubMed ID: 18079598
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibition of neuronal death by promoting degradation of intracellular amyloid beta-protein].
    Ohyagi Y; Miyoshi K; Ma L; Motomura K; Kira J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):57-62. PubMed ID: 17515111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationship of amyloid fibrils.
    Maji SK; Wang L; Greenwald J; Riek R
    FEBS Lett; 2009 Aug; 583(16):2610-7. PubMed ID: 19596006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.